Bendamustine can be a bridge to allogeneic transplantation in relapsed Hodgkin lymphoma refractory to brentuximab vedotin

Matthew Howell, Adam Gibb, John Radford, Kim Linton

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)841-843
Number of pages3
JournalBritish Journal of Haematology
Volume179
Issue number5
Early online date22 Jul 2016
DOIs
Publication statusPublished - Dec 2017

Keywords

  • Bendamustine
  • Hodgkin lymphoma
  • allogeneic transplantation
  • Brentuximab vedotin
  • refractory

Research Beacons, Institutes and Platforms

  • Cancer
  • Manchester Cancer Research Centre

Cite this